David Merrill Taylor
Architects at Cloister Ct, Chapel Hill, NC

License number
North Carolina 5730
Category
Architecture
Address
Address
222 Cloister Ct, Chapel Hill, NC 27515
LicenseFiles verified this license of Jan 19, 2017 at the North Carolina Board of Architecture.

Professional information

David Taylor Photo 1

Director, Clinical Operations At Cempra Pharmaceuticals
Position:
Director, Clinical Operations at Cempra Pharmaceuticals
Location:
Raleigh-Durham, North Carolina Area
Industry:
Pharmaceuticals
Work:
Cempra Pharmaceuticals - Chapel Hill, NC since 2012 - Director, Clinical Operations Worldwide Clinical Trials, Inc. 2010 - 2012 - Associate Director, CNS Clinical Operations POZEN 2004 - 2010 - Director, Clinical Development i3 Research/Worldwide Clinical Trials 1999 - 2004 - Sr. Project Manager Quintiles 1998 - 1999 - Manager, Clinical Operations
Education:
Pearl River High School
University of Richmond
BS, Biology
Skills:
Clinical Development, Protocol, Clinical Operations, CRO, Clinical Trials, Central Nervous System, Asthma, Clinical Research, CTMS, Pharmaceutical Industry, Clinical Pharmacology, GCP
Honor & Awards:
Certified Clinical Research Professional (CCRP)

David Taylor Photo 2

Rifaximin Anti-Rectal Dysfunction Preparation

US Patent:
2010004, Feb 25, 2010
Filed:
Mar 6, 2007
Appl. No.:
12/224774
Inventors:
Alan Safdi - Cincinnati OH, US
David Taylor - Chapel Hill NC, US
Assignee:
Salix Pharmaceuticals, Ltd. - Morrisville NC
International Classification:
A61K 31/573, A61K 31/439, A61P 1/00
US Classification:
514171, 514279
Abstract:
The present invention relates to compositions and methods for treating rectal disorders.

Architects licenses in North Carolina










Other Buildings and Land licenses in North Carolina